未登录.png)
分享.png)
收藏分享 收藏 Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis (JUL, 10.1007/s00277-024-05898-3, 2024)
Nagaharu, Keiki; Ohya, Eiko; Edahiro, Yoko; Hashimoto, Yoshinori; Ito, Tomoki; Gotoh, Akihiko; Nakamae, Mika; Kimura, Fumihiko; Koike, Michiaki; Kirito, Keita; Wada, Hideho; Usuki, Kensuke; Tanaka, Takayuki; Mori, Takehiko; Wakita, Satoshi; Saito, Toshiki I.; Saito, Akiko M.; Shimoda, Kazuya; Kurokawa, Toshiro; Tomita, Akihiro; Kiyoi, Hitoshi; Akashi, Koichi; Matsumura, Itaru; Takenaka, Katsuto; Komatsu, Norio; Ohishi, Kohshi; Tawara, Isao; Sugimoto, Yuka 分享 收藏 The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patientsShimazu, Yutaka; Kanda, Junya; Takakuwa, Teruhito; Onda, Yoshiyuki; Fukushima, Kentaro; Hotta, Masaaki; Fuchida, Shin-ichi; Uoshima, Nobuhiko; Shimura, Yuji; Tanaka, Hirokazu; Ohta, Kensuke; Shibayama, Hirohiko; Kosugi, Satoru; Yagi, Hideo; Yoshihara, Satoshi; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Matsumura, Itaru; Kuroda, Junya; Takaori-Kondo, Akifumi; Hino, Masayuki 分享 收藏 Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysisNagaharu, Keiki; Ohya, Eiko; Edahiro, Yoko; Hashimoto, Yoshinori; Ito, Tomoki; Gotoh, Akihiko; Nakamae, Mika; Kimura, Fumihiko; Koike, Michiaki; Kirito, Keita; Wada, Hideho; Usuki, Kensuke; Tanaka, Takayuki; Mori, Takehiko; Wakita, Satoshi; Saito, Toshiki I.; Saito, Akiko M.; Shimoda, Kazuya; Kurokawa, Toshiro; Tomita, Akihiro; Kiyoi, Hitoshi; Akashi, Koichi; Matsumura, Itaru; Takenaka, Katsuto; Komatsu, Norio; Ohishi, Kohshi; Tawara, Isao; Sugimoto, Yuka 分享 收藏 分享 收藏 Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective studydaratumumab后elotuzumab治疗多发性骨髓瘤的疗效恶化: 一项多中心回顾性研究Nakamura, Naokazu; Arima, Nobuyoshi; Takakuwa, Teruhito; Yoshioka, Satoshi; Imada, Kazunori; Fukushima, Kentaro; Hotta, Masaaki; Fuchida, Shin-ichi; Kanda, Junya; Uoshima, Nobuhiko; Shimura, Yuji; Tanaka, Hirokazu; Ohta, Kensuke; Kosugi, Satoru; Yagi, Hideo; Yoshihara, Satoshi; Yamamura, Ryosuke; Adachi, Yoko; Hanamoto, Hitoshi; Shibayama, Hirohiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya; Matsumura, Itaru; Hino, Masayuki 分享 收藏 分享 收藏 An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)日本多发性骨髓瘤患者每周一次卡非佐米的观察性研究 (每周CAR研究)Abe, Yu; Kubonishi, Shiro; Ri, Masaki; Iino, Masaki; Sunami, Kazutaka; Ito, Tomoki; Fukaya, Masafumi; Kitano, Toshiyuki; Ikeda, Sho; Ota, Shuichi; Kuroi, Taiga; Iriyama, Noriyoshi; Jo, Tatsuro; Adachi, Masaaki; Akahane, Daigo; Kai, Tatsuyuki; Kohara, Yoichi; Kadowaki, Norimitsu; Katayama, Teruaki 分享 收藏 分享 收藏 Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group studyKuwana, Masataka; Ito, Tomoki; Kowata, Shugo; Hatta, Yoshihiro; Fujimaki, Katsumichi; Naito, Kensuke; Kurahashi, Shingo; Kagoo, Toshiya; Tanimoto, Kazuki; Saotome, So; Tomiyama, Yoshiaki 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulinShimazu, Yutaka; Kanda, Junya; Kosugi, Satoru; Ito, Tomoki; Kaneko, Hitomi; Imada, Kazunori; Shimura, Yuji; Fuchida, Shin-ichi; Fukushima, Kentaro; Tanaka, Hirokazu; Yoshihara, Satoshi; Ohta, Kensuke; Uoshima, Nobuhiko; Yagi, Hideo; Shibayama, Hirohiko; Yamamura, Ryosuke; Tanaka, Yasuhiro; Uchiyama, Hitoji; Onda, Yoshiyuki; Adachi, Yoko; Hanamoto, Hitoshi; Takahashi, Ryoichi; Matsuda, Mitsuhiro; Miyoshi, Takashi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya 分享 收藏 Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomideShimazu, Yutaka; Kanda, Junya; Kaneko, Hitomi; Imada, Kazunori; Yamamura, Ryosuke; Kosugi, Satoru; Shimura, Yuji; Ito, Tomoki; Fuchida, Shin-ichi; Uchiyama, Hitoji; Fukushima, Kentaro; Yoshihara, Satoshi; Hanamoto, Hitoshi; Tanaka, Hirokazu; Uoshima, Nobuhiko; Ohta, Kensuke; Yagi, Hideo; Shibayama, Hirohiko; Onda, Yoshiyuki; Tanaka, Yasuhiro; Adachi, Yoko; Matsuda, Mitsuhiro; Iida, Masato; Miyoshi, Takashi; Matsui, Toshimitsu; Takahashi, Ryoichi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya 分享 收藏 分享 收藏 Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation具有临床危险因素的患者早期血浆生物标志物升高可预测异基因造血干细胞移植后非复发死亡率增加Hotta, Masaaki; Satake, Atsushi; Yoshimura, Hideaki; Fujita, Shinya; Katayama, Yuta; Ota, Shuichi; Hanamoto, Hitoshi; Oyake, Tatsuo; Ito, Shigeki; Okada, Masaya; Nakanishi, Takahisa; Ito, Tomoki; Ishii, Kazuyoshi; Nomura, Shosaku 分享 收藏 Significance of maintenance therapies in symptomatic multiple myeloma patients with HDT/ASCTNakaya, Aya; Shibayama, Hirohiko; Shimura, Yuji; Kosugi, Satoru; Tanaka, Hirokazu; Fuchida, Shin-ichi; Kanda, Junya; Uoshima, Nobuhiko; Kaneko, Hitomi; Imada, Kazunori; Ohta, Kensuke; Ito, Tomoki; Yagi, Hideo; Yoshihara, Satoshi; Hino, Masayuki; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya; Matsumura, Itaru; Kanakura, Yuzuru; Nomura, Shosaku 分享 收藏 Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myelomaTakakuwa, Teruhito; Ohta, Kensuke; Nakatani, Eiji; Ito, Tomoki; Kaneko, Hitomi; Fuchida, Shin-Ichi; Shimura, Yuji; Yagi, Hideo; Shibayama, Hirohiko; Kanda, Junya; Uchiyama, Hitoji; Kosugi, Satoru; Tanaka, Hirokazu; Kawata, Eri; Uoshima, Nobuhiko; Ishikawa, Jun; Shibano, Masaru; Karasuno, Takahiro; Shindo, Maki; Shimizu, Yoshifumi; Imada, Kazunori; Kanakura, Yuzuru; Kuroda, Junya; Hino, Masayuki; Nomura, Shosaku; Takaori-Kondo, Akifumi; Shimazaki, Chihiro; Matsumura, Itaru 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
